Oxford global: 4th Annual Drug Discovery USA Congress

About conference:

 

Oxford Global is proud to announce that early bird registration is open for the 4th Annual Drug Discovery USA Congress, 9-10 October 2017, San Diego. Across the two days 250+ senior level attendees will join us to hear 40+ presentations and case studies giving you the chance to explore the key areas shaping this exclusive field of key therapeutic areas of Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology.

 

4 interactive streams

Drug Discovery Innovation and Strategies, Enabling Technologies

Phenotypic Drug Discovery, High Throughput Technologies and RNAi Screening

Discovery Chemistry: Medicinal and Computational Chemistry

Discovery Chemistry: Novel Approaches to Drug Design

 

A truly unmissable congress; hear from internationally renowned senior experts in the cell & gene therapy field, including:

 

Strategic Use of Fluorine & Analysis of the Impact of Fluorine Substitution on P-Glycoprotein Mediated Efflux, Permeability, Lipophilicity & Metabolic Stability

by Martin Pettersson, Medicinal Chemistry Team Leader, Pfizer

 

Chemistry & Chemical Biology Technologies for Improving Probability of Success

by Anil Vasudevan, Director, Discovery Chemistry & Technology, AbbVie

 

A RNAi Therapeutic Approach for Cancer Treatment

by Patrick Liu, Founder, President & CEO, Sirnaomics

 

Lung Specific Delivery Using Caveolae Associated Protein PV-1 Antibody Improves Drug Efficacy

by Ping Tsui, Associate Director & Principal Scientist, Antibody Discovery & Protein Engineering, MedImmune

 

2017 Drug Discovery USA Speakers Include:

 

 

Contact us

Angela Fernandez Saez
Tel: +447956 710599
Email: a.fernandez@oxfordglobal.co.uk